COMP <GO>
NATR vs RNAC // EV/EBITDA & P/E VALUATION
Nature's Sunshine Products Inc. (NASDAQ) VS. Cartesian Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: NATR 8
— RNAC 0
■ METRIC PARITY
LAST: $12.25 (-0.24%) • MKT CAP: $216.1M
valuation
4.0x
LAST: $6.49 (-3.85%) • MKT CAP: $204.2M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NATR VS. RNAC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NATR | RNAC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 72.40% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 28.90% | -35.00% | +63.90 | NATR | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 4.0x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 13.35% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | 5.20% | -60.00% | +65.20 | NATR | /operating-margins <GO> |
| Net Profit Margin | 4.10% | -60.00% | +64.10 | NATR | /net-margins <GO> |
| Revenue Growth (YoY) | 5.70% | -65.00% | +70.70 | NATR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.33 | 0.20 | +4.13 | NATR | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 2/9 | +6.00 | NATR | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 41.8 | 39.7 | +2.10 | NATR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 10.3x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $216.1M | $204.2M | $11.8M | NATR | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NATR REV | RNAC REV | NATR GROSS % | RNAC GROSS % | NATR FCF | RNAC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $480.1M | $400.0K | 72.4% | — | $28.8M | -$79.4M |
| FY 2024 | $454.4M | $38.3M | 71.5% | — | $14.3M | -$32.8M |
| FY 2023 | $445.3M | $26.0M | — | — | $41.2M | -$51.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NATR // BETA —
RNAC // BETA —